NCT06161818View on ClinicalTrials.gov

Total Neoadjuvant Therapy for Adenocarcinoma of the OESophagus and Oesophagogastric Junction: TNT-OES-2 Trial

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

September 1, 2029

Study Completion Date

December 1, 2029

Conditions
Esophageal CancerAdenocarcinoma of the Esophagus
Interventions
DRUG

FLOT-CROSS or CROSS-FLOT

Randomization between TNT FLOT-CROSS and TNT CROSS-FLOT

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER